1.3 Percent of Children, 6.9 Percent of Adults Ever Had Long COVID
TUESDAY, Sept. 26, 2023 (HealthDay News) — In 2022, 1.3 percent of children and 6.9 percent of adults had ever had long COVID, according to two September data briefs published by the U.S. Centers for Disease Control and Prevention National Center for…
Learn MoreSuicide Risk Increased for Some U.S. Health Care Workers
TUESDAY, Sept. 26, 2023 (HealthDay News) — Registered nurses, health technicians, and health care support workers have an increased risk for suicide compared with non-health care workers, according to a study published in the Sept. 26 issue of the Jo…
Learn MoreSuicide Risk Increased for Some U.S. Health Care Workers
TUESDAY, Sept. 26, 2023 (HealthDay News) — Registered nurses, health technicians, and health care support workers have an increased risk for suicide compared with non-health care workers, according to a study published in the Sept. 26 issue of the Jo…
Learn MoreOnce-Weekly Insulin Icodec Superior for HbA1c in Type 2 Diabetes
TUESDAY, Sept. 26, 2023 (HealthDay News) — For insulin-naive adults with type 2 diabetes, once-weekly insulin icodec (icodec) titrated with a dosing guide app (icodec with app) is superior for change in glycated hemoglobin A1c (HbA1c) level versus on…
Learn MoreaHSCT Beneficial for Most Patients With Relapsing-Remitting MS
TUESDAY, Sept. 26, 2023 (HealthDay News) — Autologous hematopoietic stem cell transplantation (aHSCT) for treatment of relapsing-remitting multiple sclerosis (RRMS) yields freedom from disease activity for most patients, according to a study publishe…
Learn MoreElevated BP in Adolescence Linked to Increased Cardiovascular Risk for Males
TUESDAY, Sept. 26, 2023 (HealthDay News) — For males, increased blood pressure (BP) in late adolescence is associated with an increased risk for cardiovascular events, according to a study published online Sept. 26 in the Annals of Internal Medicine….
Learn MoreBoth Ciclosporin, Methotrexate Effective for Severe Eczema in Children
TUESDAY, Sept. 26, 2023 (HealthDay News) — For children and young people with severe atopic dermatitis (AD), ciclosporin (CyA) and methotrexate (MTX) are both effective over 36 weeks, according to a study published online Sept. 19 in the British Jour…
Learn MoreBurden of Heart Disease Considerable for American Indians, Alaska Natives
TUESDAY, Sept. 26, 2023 (HealthDay News) — American Indian and Alaska Native patients with Medicare insurance have a considerable burden of cardiovascular disease, according to a study published online Sept. 22 in JAMA Network Open.Lauren A. Eberly, …
Learn MoreIncrease in Types 1 and 2 Diabetes Seen in U.S. Youth During Pandemic
TUESDAY, Sept. 26, 2023 (HealthDay News) — The incidence of type 1 and type 2 diabetes increased among U.S. youth during the COVID-19 pandemic, according to a study published online Sept. 21 in JAMA Network Open.Matthew T. Mefford, Ph.D., from Kaiser…
Learn MoreReduced Mortality Risk Seen for Patients With Vitiligo
TUESDAY, Sept. 26, 2023 (HealthDay News) — Patients with vitiligo may have a reduced risk for mortality, according to a study published online Sept. 14 in the Journal of Investigative Dermatology.Hyun Jeong Ju, M.D., Ph.D., from the St. Vincent’s Hos…
Learn More